INTERNATIONAL PATENT: SANOFI FILES APPLICATION FOR "CEREBLON LIGASE MODULATOR AND BCMA NK CELL ENGAGER COMBINATION THERAPY"

GENEVA, Feb. 3 -- SANOFI (46 avenue de la Grande Armee75017 Paris) filed a patent application (PCT/IB2025/057431) for "CEREBLON LIGASE MODULATOR AND BCMA NK CELL ENGAGER COMBINATION THERAPY" on Jul 23, 2025. With publication no. WO/2026/022712, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHIRON, Marielle (c/o Sanofi, Patent Department46 avenue de la Grande Armee75017 Paris), VAN DE VELDE, Helgi (c/o Sanofi Belgium,Leonardo Da Vinci Laan 19, Airport Plaza Montreal Building1831 Diegem), VIRONE-ODDOS, Angela (c/o Sanofi,...